Hundreds of billions of Kangmei to buy arms dealers, invest in dozens of hospitals, host more than 100 hospital pharmacies

Pharmaceutical network on January 11 unknowingly, this hundreds of billions of market value of pharmaceutical companies, has acquired, invested in about 10 medical device operating enterprises, its bottom gas from the investment of dozens of, more than 100 hospitalsAfter the "Big Mac" invaded the circulation of medical devices, a large number of medical device operators within its sphere of influence, or will face the "tragic situation" of ash-and-smokethe company is named Kangmei Pharmaceutical Co., Ltd("Conmei Pharmaceuticals")January 9, Kangmei Pharmaceuticals announced that the wholly-owned subsidiary Shanghai Kangmei Pharmaceutical Co., Ltd("Shanghai Kangmei") intends to acquire 80% of Shandong Meisheng Medical Devices Co., Ltdin cash, with a bid of 16.099 million yuanMeisheng Medical is mainly engaged in one, two, three categories of medical equipment supplies wholesale and retail business, in Shandong Province has high-value supplies distribution service teamthe completion of the acquisition, Kangmei regional medical device sales platform will be extended to the scope of Shandong Province's acquisition of Myan Medical is the latest acquisition by Commeryand Cypress Blue Devices noted that in the past 2017, Kangmei has made a series of efforts in the field of medical devices, within a year to buy a number of medical device business enterprises in many parts of the country, and even once to buy a monthly arms dealer!In August 2017, Kangmei Pharmaceuticals announced that Shanghai Kangmei will acquire a 100% stake in Hainan Yijing NewTechnology Co., Ltdfor a total price of 1.79 million yuanYijing's new main business for the second and third category ofsales, customers are mainly public hospitals in Hainan ProvinceJuly 2017, Kangmei Pharmaceuticals announced that Shanghai Kangmei will acquire Guangzhou for a total price of approximately RMB22.92 million and hold an 80% stake in Medical Technology Development Co., LtdGuangzhou and hold the main business for the third category of medical equipment sales, regional coverage is mainly in Guangdong ProvinceJune 2017, Kangmei Pharmaceuticals announced that Shanghai Kangmei will acquire a 100% stake in Shanxi Hongkang Health Trading Co., Ltdfor a total price of RMB4.802 million, The main business of Hao Hongkang Jian is the sale of two and three types of medical equipment, and has established a special sales team of the major hospitals in Taiyuan CityMay 2017, Kangmei Pharmaceuticals announced that it would acquire a 100% stake in Chongqing Rite-Ty Pharmaceutical Co., Ltdfor a total price of 8.61 million yuanRuitai Pharmaceutical's main business for chemical drugs, traditional Chinese medicine and medical equipment (including one, two, three) sales, the area of coverage is mainly ChongqingApril 2017, Kangmei Pharmaceuticals announced that Shanghai Kangmei will acquire a 100% stake in Baotou City Huaying Medical Devices Co., Ltdfor a total price of about 970,000 yuanHuaying Medical's main business for the sale of three types of medical devices, customers for Baotou City and surrounding hospitalsMarch 2017, Kangmei Pharmaceuticals announced that Shanghai Kangmei will acquire a 100% stake in Fuzhou Zhongbo Hengbang Trading Co., Ltdfor a total price of about 1.25 million yuanThe main business of Zhongbo Hengbang is the sale of second and third types of medical equipment, and the customers are hospitals in various regions of Fujianin the ongoing mergers and acquisitions, Kangmei is also through their own investment to open a company, with local high-quality manufacturers in the form of cooperation, their own medical device sales platform to further expandDecember 2017, Kangmei Pharmaceuticals announced that Shanghai Kangmei Investment has established a wholly-owned subsidiary, Kangmettaibang (Beijing) Medical Devices Co., Ltd., with an investment value of 50 million yuannew company is mainly engaged in medical device sales, the goal is to integrate the North China market medical device sales business, to create a regional medical device platform for North China August 2017, Kangmei Pharmaceuticals announced that Shanghai Kangmei and Huzhou Tukang Medical Devices Co., Ltd., Taizhou City Kangliwei Business Services Co., Ltd., respectively, in Hangzhou, Zhejiang Province, Jiangsu Taizhou set up a joint venture medical device operating Shanghai Kangmei accounted for 80% of the shares through successive mergers and acquisitions, investment behavior, Kangmei in a year will be in the field of medical device sales reached in Zhejiang, Jiangsu, Beijing, Guangdong, Fujian, Chongqing, Hainan, Shandong, Shanxi, Inner Mongolia and other provinces invested in dozens of hospitals, hosted more than 100 hospital pharmacies
Kangmei's massive acquisition of the arms manufacturer behind, because of its super-strong medical device product terminal digestion capacity - since 2014, Kangmei action frequency, and announced in bulk, the industry shocked Only in the year kangmei has announced the custody of Jilin Tonghua, Guangdong Puning, Guangdong Huilai, Liaoning Benxi 87 hospital pharmacies To date, Comey has hosted more than 100 hospital pharmacies the drugs used in these hospital pharmacies are supplied and distributed centrally by Kangmei, and the settlement price of the drugs by Kangmei and the hospital is based on the unified tender-linked price in addition to the hospital pharmacy, Kangmei also invested in the hospital, has so far invested in the management of Puning Kangmei Hospital, Meihekou Central Hospital, Rongchang Zhong Hospital, Kaiyuan City Center Hospital, Tonghua County People's Hospital and dozens of other public hospitals Recently, one of the hospitals that Kangmei is going to buy is the Hubei Tongcheng County People's Hospital On January 9, Kangmei issued a notice, said to invest 1.08 billion yuan, in accordance with the law, regulations in the form of entrusted to manage Tongcheng County People's Hospital, investment in the construction of "Kangmei Tongcheng People's Hospital", to build a three-level joint medical complex, the comprehensive construction of radiation in the three provinces surrounding counties and cities of the regional health center, of which Kangmei accounted for 80% of the shares in addition to this, Kangmei will invest 5 billion yuan in Chongqing, 5 billion yuan in Guiyang, 8 billion yuan in Kunming into the big health industry, which generally includes Chinese herbal medicine, distribution and other projects according to relevant information, Kangmei in the hospital direct camp, with more than 2500 hospitals to establish a long-term cooperative relations, the total number of cooperative medical institutions reached more than 250 million outpatients a year has proven that through its investment in hospitals and hospital-hosting pharmacies, sales of medicines and Chinese medicine tablets have continued to grow now from Kangmei into medical devices, the continuous acquisition of medical device business enterprises, and the bid is generally not high, its intention is very obvious, is to obtain medical device distribution qualifications because the hospital is their own, other arms dealers can not come, Kangmei to do a large medical device distribution ambition, the chance of success far more ordinary arms dealers at present, Kangmei business includes hospital direct operation, pharmacy custody, commercial wholesale, chain pharmacy distribution, e-commerce, direct sales and so on through its own investment in the construction, trusteeship and cooperative hospital channels, Kangmei's performance has been rapid growth, in 2015, 2016 and 2017, its operating income was 18,067 million, 21.642 billion, 13.262 billion, the growth rate of about 18%, its market value is long-term more than 100 billion, is the listed pharmaceutical companies only a few billion enterprises with a market value of more than 100 billion.